Viridian Therapeutics Inc (VRDN NASDAQ) stock market data APIs
$27.4953
0.12(0.4%)
as of November 7, 2025
Try our APIs with
free plan!
Viridian Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. The company's product pipeline includes veligrotug, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R monoclonal antibodies targeting IGF-1R and engineered of half-life extension technology, which is in Phase 3 clinical trial for the treatment of TED. It also develops portfolio of engineered anti-neonatal Fc receptor inhibitors, such as VRDN-006 and VRDN-008 for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Prev. Close
27.4953
Open
27.6132
High
27.599
Low
26.6748
52 wk Range
9.9-28.6
Market Cap
2 625 M
Shares Outstanding
95 368 K
Revenue
70 789 K
EPS
-0.34
Beta
0.945
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Viridian Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Viridian Therapeutics Inc data using free add-ons & libraries
Get Viridian Therapeutics Inc Fundamental Data
Viridian Therapeutics Inc Fundamental data includes:
- Net Revenue: 70 789 K
- EBITDA: -327 655 008
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -0.9532
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Viridian Therapeutics Inc News
New
Viridian Therapeutics GAAP EPS of -$0.34 beats by $0.68, revenue of $70.57M
* Viridian Therapeutics press release [https://seekingalpha.com/pr/20293955-viridian-therapeutics-reports-third-quarter-2025-financial-results-and-highlights-recent] (VRDN [https://seekingalpha.com/...
Insiders Scoop Up Shares of This Biotech IPO, Energy Giant, and More
JHVEPhoto / iStock Editorial via Getty Images In the past week or so, beneficial owners took advantage of MapLight Therapeutics Inc.’s (NASDAQ: MPLT) initial public offering. Meanwhile, the executi...
Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates
Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.82. This compares to a loss of $1.15 per share a year ago. Thes...
Astria, Viridian Therapeutics, and More Stocks See Action From Activist Investors
13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities. Continue Reading View Comments
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
